Cargando…

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV

BACKGROUND: We investigated the prevalence of depression in hemodialysis (HD) patients using the Center for Epidemiologic Studies for Depression (CES-D) scale and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID) and compared the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Tetsu, Yasui-Furukori, Norio, Sugawara, Norio, Ogasawara, Kohei, Katagai, Koki, Saito, Hisao, Sawada, Kaori, Takahashi, Ippei, Nakamura, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053379/
https://www.ncbi.nlm.nih.gov/pubmed/27757034
http://dx.doi.org/10.2147/NDT.S106817
_version_ 1782458402459353088
author Tomita, Tetsu
Yasui-Furukori, Norio
Sugawara, Norio
Ogasawara, Kohei
Katagai, Koki
Saito, Hisao
Sawada, Kaori
Takahashi, Ippei
Nakamura, Kazuhiko
author_facet Tomita, Tetsu
Yasui-Furukori, Norio
Sugawara, Norio
Ogasawara, Kohei
Katagai, Koki
Saito, Hisao
Sawada, Kaori
Takahashi, Ippei
Nakamura, Kazuhiko
author_sort Tomita, Tetsu
collection PubMed
description BACKGROUND: We investigated the prevalence of depression in hemodialysis (HD) patients using the Center for Epidemiologic Studies for Depression (CES-D) scale and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID) and compared the rates with those of community dwelling people in Japan. PATIENTS AND METHODS: A total of 99 patients undergoing HD were recruited. Blood sampling was performed no later than 2 weeks prior to assessment. As a reference group for SCID and CES-D evaluation, 404 age- and sex-matched healthy controls who had participated in the Iwaki Health Promotion Project were included in this study. The SCID and the CES-D scale were administered to all participants to diagnose their depression. Participants who met the criteria of a major depressive episode according to the SCID were classified as SCID depression and the participants whose CES-D score was 16 or higher were classified as CES-D depression. RESULTS: Ninety-nine HD patients completed the evaluation and data collection. There were no significant differences in age, sex, or CES-D scores between HD patients and controls. There were 12 cases of SCID depression in HD patients and four cases in controls. There was a significant difference between HD patients and controls in the prevalence of SCID depression. There were no significant differences between the two groups with regard to demographic or clinical data. There were 19 HD patients and 24 controls who showed CES-D depression. There was no significant difference between HD patients and controls in the prevalence of CES-D depression. There was a significant difference in potassium level between the two groups, but there were no significant differences in any of the other items. CONCLUSION: There were significantly more HD patients showing SCID depression than controls in the present study. In clinical settings, the SCID might be useful in surveying cases of depression detected by screening tools among HD patients.
format Online
Article
Text
id pubmed-5053379
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50533792016-10-18 Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV Tomita, Tetsu Yasui-Furukori, Norio Sugawara, Norio Ogasawara, Kohei Katagai, Koki Saito, Hisao Sawada, Kaori Takahashi, Ippei Nakamura, Kazuhiko Neuropsychiatr Dis Treat Original Research BACKGROUND: We investigated the prevalence of depression in hemodialysis (HD) patients using the Center for Epidemiologic Studies for Depression (CES-D) scale and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID) and compared the rates with those of community dwelling people in Japan. PATIENTS AND METHODS: A total of 99 patients undergoing HD were recruited. Blood sampling was performed no later than 2 weeks prior to assessment. As a reference group for SCID and CES-D evaluation, 404 age- and sex-matched healthy controls who had participated in the Iwaki Health Promotion Project were included in this study. The SCID and the CES-D scale were administered to all participants to diagnose their depression. Participants who met the criteria of a major depressive episode according to the SCID were classified as SCID depression and the participants whose CES-D score was 16 or higher were classified as CES-D depression. RESULTS: Ninety-nine HD patients completed the evaluation and data collection. There were no significant differences in age, sex, or CES-D scores between HD patients and controls. There were 12 cases of SCID depression in HD patients and four cases in controls. There was a significant difference between HD patients and controls in the prevalence of SCID depression. There were no significant differences between the two groups with regard to demographic or clinical data. There were 19 HD patients and 24 controls who showed CES-D depression. There was no significant difference between HD patients and controls in the prevalence of CES-D depression. There was a significant difference in potassium level between the two groups, but there were no significant differences in any of the other items. CONCLUSION: There were significantly more HD patients showing SCID depression than controls in the present study. In clinical settings, the SCID might be useful in surveying cases of depression detected by screening tools among HD patients. Dove Medical Press 2016-09-30 /pmc/articles/PMC5053379/ /pubmed/27757034 http://dx.doi.org/10.2147/NDT.S106817 Text en © 2016 Tomita et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tomita, Tetsu
Yasui-Furukori, Norio
Sugawara, Norio
Ogasawara, Kohei
Katagai, Koki
Saito, Hisao
Sawada, Kaori
Takahashi, Ippei
Nakamura, Kazuhiko
Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title_full Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title_fullStr Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title_full_unstemmed Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title_short Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
title_sort prevalence of major depressive disorder among hemodialysis patients compared with healthy people in japan using the structured clinical interview for dsm-iv
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053379/
https://www.ncbi.nlm.nih.gov/pubmed/27757034
http://dx.doi.org/10.2147/NDT.S106817
work_keys_str_mv AT tomitatetsu prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT yasuifurukorinorio prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT sugawaranorio prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT ogasawarakohei prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT katagaikoki prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT saitohisao prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT sawadakaori prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT takahashiippei prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv
AT nakamurakazuhiko prevalenceofmajordepressivedisorderamonghemodialysispatientscomparedwithhealthypeopleinjapanusingthestructuredclinicalinterviewfordsmiv